Adverse effect of antineoplastic and immunosup drugs, init

This code signifies a patient experiencing an unintended and harmful reaction to a medication used to treat cancer or suppress the immune system. These adverse effects are not due to an overdose or poisoning, but rather a side effect occurring at therapeutic doses. The "initial encounter" indicates the patient is receiving active treatment for this specific adverse effect.

Apply this code when a patient presents for the first time to receive care for an adverse reaction to chemotherapy, immunotherapy, or other immunosuppressive agents. Examples include myelosuppression, severe nausea/vomiting, mucositis, or organ toxicity directly attributable to these drug classes. This code is appropriate when the adverse effect is the primary reason for the encounter.

• Always sequence this code as the primary diagnosis when the adverse effect is the reason for the encounter.
• Code the specific manifestation of the adverse effect (e.g., neutropenia, acute kidney failure) as a secondary diagnosis.
• Ensure documentation clearly links the adverse effect to the antineoplastic or immunosuppressive drug.